Evidence map›Paper›PMID 36454309›Full record

ArticleChild's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery2023

Sodium fluorescein in pediatric oncological neurosurgery: a pilot study on 50 children.

Camilla de Laurentis, Fred Bteich, Pierre Aurélien Beuriat, Laryssa Crystinne Azevedo Almeida, Sylvie Combet, Carmine Mottolese, Matthieu Vinchon, Alexandru Szathmari, Federico Di Rocco

Abstract read
PubMed Publisher
In one paragraph

Article in Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Role of sodium fluorescein in pediatric low-grade glioma surgery: an update.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2024
    Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Camilla de LaurentisPediatric Neurosurgery, Hôpital Femme Mère Enfant, Lyon, France.
Fred BteichPediatric Neurosurgery, Hôpital Femme Mère Enfant, Lyon, France.
Pierre Aurélien BeuriatPediatric Neurosurgery, Hôpital Femme Mère Enfant, Lyon, France.
Laryssa Crystinne Azevedo AlmeidaPediatric Neurosurgery, Hôpital Femme Mère Enfant, Lyon, France.
Sylvie CombetPediatric Anesthesiology, Hôpital Femme Mère Enfant, Lyon, France.
Carmine MottolesePediatric Neurosurgery, Hôpital Femme Mère Enfant, Lyon, France.
Matthieu VinchonPediatric Neurosurgery, Hôpital Femme Mère Enfant, Lyon, France.
Alexandru SzathmariPediatric Neurosurgery, Hôpital Femme Mère Enfant, Lyon, France.
Federico Di RoccoPediatric Neurosurgery, Hôpital Femme Mère Enfant, Lyon, France. federico.dirocco@chu-lyon.fr.
Hôpital Femme Mère Enfant · FRUniversité Claude Bernard Lyon 1 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSodium fluorescein (SF) is currently considered a valid intraoperative adjunct in the resection of high-grade brain lesions in adults. Experiences in pediatric groups and in low-grade gliomas and other low-grade lesions are still limited in literature, and subjective evaluation of fluorescence is still a limitation. MATERIAL AND

methodsThis study retrospectively reviewed all patients with brain or spine lesions operated on from September 2021 to July 2022 in the Pediatric Neurosurgery Unit of Hôpital Femme Mère Enfant, Lyon, who had received 5 mg/kg of 10%. Surgery was performed using a YELLOW560 filter at crucial times. At the end of surgery, the first operator completed a questionnaire, including his opinion on whether SF had been useful in tumor resection, recorded as a binary variable. Post hoc, surgical images were reviewed using ImageJ, an open-source Java image processing platform. In order to compare independent discrete variables, we applied the Student's t test, and we applied the Chi-square or Fisher exact test for binary variables. A threshold of p < 0.05 was set for statistical significance.

resultsWe included 50 pediatric patients (0.2-17.6 years old). Forty/50 lesions showed SF uptake (80%). The differentiation between healthy and affected tissue, thanks to SF, subjectively evaluated by the surgeon, had as objective counterpart the statistically significant higher brightness of green in lesions, registered by the software (p < 0.001). SF overall allowed a good differentiation in 33/50 lesions, and overall utility of SF has been noted in 67% of them. When specifically considering gliomas, overall utility reached 75%.

conclusionSF is a feasible, safe, and useful intraoperative adjunct in pediatric neurosurgery. In particular, it seems to have a promising role in some low-grade infiltrating glial tumors. The subjective evaluation of fluorescence seems to be reliable with respect to image analyses software.

Indexed as

Brain NeoplasmsGliomaNeurosurgeryAdolescentAdultChildChild, PreschoolFluoresceinHumansInfantPilot ProjectsRetrospective StudiesFluoresceinBrain lesionsPediatric oncological neurosurgerySodium fluorescein

Identifiers

PMID36454309
OpenAlexW4310570748

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.